Adjuvant Furmonertinib in Stage IA With High Risk Factors and Stage IB Non-small Cell Lung Cancer
Clinical trial NCT05445310 · UNKNOWN
Trial details
- NCT number
- NCT05445310
- Sponsor
- Peking Union Medical College Hospital
- Status
- UNKNOWN
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2022-08-06
- Primary completion
- 2026-07-01
- Enrollment
- 114
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.